Systematic Review: Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. 11 May, 2022 | 11:04h | UTC Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women – Cochrane Library Summary: Risedronate for preventing fractures caused by osteoporosis in postmenopausal women – Cochrane Library